VANI
Vivani Medical Inc.
1.30$
+1.6%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 221.6% | 462.7% | 111.7% | 50.4% | 62.2% | 59.9% | 68.4% | 43.8% | 79.4% | 90.6% | 64.8% | 72.8% | 77.1% | 24.9% | – | – | – | – | – | – | – | 50.0% | – | – | – | – | – | – | – | 18.9% | – | – | – | 22.4% | – | – | – | – | – | – | – | |
| -121.6% | -362.7% | -11.7% | 49.6% | 37.8% | 40.1% | 31.6% | 56.2% | 20.6% | 9.4% | 35.2% | 27.2% | 22.9% | 75.1% | – | – | – | – | – | – | – | 50.0% | – | – | – | – | – | – | – | -18.9% | – | – | – | -22.4% | – | – | – | – | – | – | – | |
| 134.6% | 291.0% | 183.1% | 87.2% | 113.4% | 73.0% | 253.5% | 127.0% | 119.0% | 138.0% | 193.5% | 268.0% | 715.9% | 1,025.2% | – | – | – | – | – | – | – | 1,144,230.8% | – | – | – | – | – | – | – | 908.9% | – | – | – | 1,079.6% | – | – | – | – | – | – | – | |
| 220.8% | 342.0% | 271.7% | 129.7% | 157.0% | 88.8% | 332.4% | 138.0% | 103.8% | 140.6% | 217.1% | 176.0% | 461.4% | 471.4% | – | – | – | – | – | – | – | 220,384.6% | – | – | – | – | – | – | – | 291.3% | – | – | – | 542.0% | – | – | – | – | – | – | – | |
| 598.6% | 1,089.5% | 737.1% | 356.9% | 457.0% | 279.2% | 1,032.5% | 475.0% | 401.1% | 480.4% | 686.3% | 617.6% | 1,637.1% | 1,698.0% | – | – | – | – | – | – | – | 1,364,615.4% | – | – | – | – | – | – | – | 1,181.3% | – | – | – | 1,600.8% | – | – | – | – | – | – | – | |
| -720.3% | -1,452.2% | -748.8% | -307.3% | -419.2% | -239.1% | -1,000.9% | -418.9% | -380.5% | -502.4% | -866.0% | -658.4% | -1,614.2% | -1,622.9% | – | – | – | – | – | – | – | -1,364,615.4% | – | – | – | – | – | – | – | -1,200.2% | – | – | – | -1,623.1% | – | – | – | – | – | – | – | |
| – | – | – | – | 2.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 54.6% | – | – | – | – | – | – | – | – | – | – | – | |
| -719.4% | -1,450.3% | -748.1% | -306.0% | -417.1% | -238.3% | -999.3% | -417.5% | -379.4% | -501.3% | -859.9% | -658.3% | -1,606.8% | -1,583.1% | – | – | – | – | – | – | – | -1,392,307.7% | – | – | – | – | – | – | – | -1,163.3% | – | – | – | -1,520.1% | – | – | – | – | – | – | – | |
| 0.8% | 1.8% | 0.7% | 1.3% | 4.1% | 0.8% | 1.6% | 1.4% | 1.1% | 1.1% | 6.0% | 0.1% | 7.4% | 51.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 54.6% | – | – | – | -14.0% | – | – | – | – | – | – | – | |
| -719.4% | -1,450.3% | -748.1% | -306.0% | -417.1% | -238.3% | -999.3% | -417.5% | -379.4% | -501.3% | -859.9% | -658.3% | -1,606.8% | -1,583.1% | – | – | – | – | – | – | – | -1,392,307.7% | – | – | – | – | – | – | – | -1,163.3% | – | – | – | -1,520.1% | – | – | – | – | – | – | – | |
| -710.3% | -1,433.4% | -736.9% | -300.8% | -409.9% | -234.7% | -987.9% | -411.6% | -374.7% | -495.3% | -851.2% | -650.8% | -1,586.2% | -1,561.4% | – | – | – | – | – | – | – | -1,360,384.6% | – | – | – | – | – | – | – | -1,144.4% | – | – | – | -1,497.7% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.